ACCEL-DAPAGLIFLOZIN

उत्पाद अवलोकन

About ACCEL-DAPAGLIFLOZIN

ACCEL-DAPAGLIFLOZIN is a prescription medication containing the active ingredient Dapagliflozin, used in the treatment of type 2 diabetes. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidneys and promoting its excretion in the urine.

Key Benefits & Uses

• Reduces blood sugar levels in patients with type 2 diabetes
• Helps to improve glycemic control and reduce the risk of complications associated with diabetes
• May also be used to reduce blood pressure and body weight in patients with type 2 diabetes

Active Ingredient & Action

Dapagliflozin, the active ingredient in ACCEL-DAPAGLIFLOZIN, works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the urine back into the bloodstream. By blocking this protein, Dapagliflozin increases the excretion of glucose in the urine, thereby reducing blood sugar levels.

Important Notes

ACCEL-DAPAGLIFLOZIN is available only by prescription and should be used under the guidance of a healthcare professional. Patients with kidney disease or heart failure should use this medication with caution and under close medical supervision. Common side effects may include genital yeast infections, urinary tract infections, and increased risk of diabetic ketoacidosis.